From 0 to 300K Sessions: Is Psychedelic Therapy The Ultimate Treatment for Mental Health Issues?

36:07

Access AI content by logging in

Dylan Beynon, CEO of Mindbloom, talks about why he started this company, the impact of Ketamine and MDMA therapy in our society, and how this industry is just going to grow bigger in the future. TIME-STAMPED SHOW NOTES: (00:00) - Know more about Dylan Beynon and his company, Mindbloom (02:30) - Why did Dylan Beynon start Mindbloom (06:22) - Dylan Beynon talks more about MDMA therapy (13:30) - Pricing and treatment programs that Mindbloom offer (15:30) - Dylan Beynon’s personal opinion on MDMA and Ketamine therapy (22:12) - The largest peer review clinical study for psychedelic and ketamine therapy  (25:20) - The best mental health tool for Dylan Beynon (27:53) - Dylan Beynon talks about Vipassana Meditation (36:00) - Where to find Dylan Beynon and learn more about Mindbloom Go to https://www.marketingschool.io to learn more! Don’t forget to help us grow by subscribing and liking on YouTube! Leave Some Feedback: What should we talk about next? Please let us know in the comments below Did you enjoy this episode? If so, please leave a short review. Connect with Us:  Single Grain << Eric’s ad agency NP Digital << Neil’s ad agency X @neilpatel  X @ericosiu Learn more about your ad choices. Visit megaphone.fm/adchoices See omnystudio.com/listener for privacy information.